Latest news
ACADIA: Buy Rating Reiterated as Analyst Sees Favorable Risk-Reward Ahead of RADIANT Readout; $37 Price Target Unchanged - TipRanksTipRanks · Wed, 05 Aug 2026 18:36:33 GMTAcadia Pharmaceuticals: Why I'm Bullish Ahead Of The RADIANT Readout (NASDAQ:ACAD) - Seeking AlphaSeeking Alpha · Mon, 27 Jul 2026 07:00:00 GMT